According to Fact.MR, a market research and competitive intelligence service, global sales of cerebral angiography are expected to reach $70 million by the end of 2027.
The increasing demand for cerebral angiography in hospitals is driven by the availability of skilled medical professionals, the use of advanced detection technologies in radiology departments to identify blood vessel damage caused by trauma or injury, and diagnose cardiovascular diseases such as artery narrowing and aneurysms. Additionally, advances in diagnostic technology continue to propel growth in the Cerebral Angiography Market.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.factmr.com/connectus/sample?flag=S&rep_id=7693
The market in the United States is growing as a result of the widespread use of minimally invasive treatments, reimbursement availability, rising adoption of cerebral thrombectomy devices, an aging population, a strong network of medical device manufacturers, and an increasing number of hospitals with lucrative funding opportunities. Cardiovascular disease treatment with 3D printing is becoming more common, and it may eventually be used to prevent disease. Aortic valve failure can be treated without the need for prosthetic valves by using 3D-printed heart valves made from living tissue. Innovation and developments in the healthcare industry are driving the cerebral angiography market.
The U.S. market is booming due to quick product clearance processes and rising angiography device utilization as a result of
Opportunities Ahead for Key Providers of Cerebral Angiography Devices
The use of 3D printing in cardiovascular disease treatment is gaining traction, with potential future applications in disease prevention. For example, heart valves 3D printed from living tissue may offer a solution for aortic valve failure without the need for prosthetic valves. Innovation and investments in the healthcare sector are driving growth in the cerebral angiography market.
Brain aneurysms can result from factors such as smoking, high blood pressure, and family history. They are primarily caused by degenerative changes in the arterial wall and the pressure from blood flow pulsations in the brain's arteries. The rising global incidence of brain aneurysms is fueling market expansion.
Minimally-invasive techniques, which involve small incisions or the insertion of tiny devices or implants, have gained widespread acceptance. These procedures offer several advantages, including quicker recovery, less pain, and reduced muscle, nerve, and tissue stress. With fewer cuts, lower bleeding and scarring, less pain, faster recovery, and shorter hospital stays, minimally-invasive surgeries are becoming increasingly preferred.
Factors That Could Hinder Demand for Cerebral Angiography Systems
Several factors are limiting the growth of the cerebral angiography market, including a shortage of skilled professionals, an increase in product recalls, stringent medical device safety regulations, and insufficient reimbursement policies.
Additionally, the high cost of advanced cerebral angiography equipment, driven by continuous innovation and new features, is hindering broader adoption. The increased price of these devices also raises treatment costs, making it difficult for patients to afford the procedure.
Country-wise Insights
The U.S. cerebral angiography market is growing due to the widespread adoption of minimally-invasive treatments, availability of reimbursements, increasing use of cerebral thrombectomy devices, an aging population, a robust network of medical device manufacturers, and the growing number of hospitals with substantial funding opportunities.
The market is further expanding as a result of rapid product approval processes and the rising use of angiography devices, driven by the high volume of angiography screening procedures being performed.
Category-wise Insights
The cerebral angiography market is segmented by technology into magnetic resonance angiography, computed tomography, ultrasound, nuclear imaging, and X-ray. Magnetic resonance angiography holds the largest share of the global market.
Magnetic resonance angiography is one of the most commonly used diagnostic imaging techniques worldwide. It is considered crucial for diagnosing, managing, and treating various serious conditions.
This technology is regarded as a major breakthrough in medical imaging, offering non-invasive, potentially safe procedures that provide detailed images of body abnormalities. As the global incidence of cancer and trauma rises, the demand for imaging equipment to aid in diagnosis continues to increase.
The cerebral angiography market is divided into hospitals, diagnostic imaging centers, and other end users.
Hospitals dominate the market due to their wide range of patients, access to resources, purchasing power for advanced technologies, and strong healthcare infrastructure. Factors such as the availability of skilled labor, government funding, and increased awareness of early disease diagnosis contribute to the hospital segment's growth.
Hospitals are more accessible and affordable compared to specialty clinics, attracting a large patient base, especially those with cardiovascular conditions. Additionally, hospitals benefit from trade agreements and bulk purchase discounts, boosting their profitability.
Segmentation of Cerebral Angiography Industry Research
-
By Technology :
- Magnetic Resonance Angiography
- Computed Tomography
- Ultrasound
- Nuclear Imaging
- X-ray
-
By End User :
- Hospitals
- Diagnostic Imaging Centers
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
Comments
0 comment